Clinical trial
ODISSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY (ODISSEY-SCD
NCT07545512 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ODISSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Cardiac Death in Moderated LVEF in ischEmic cardiomyopathY (ODISSEY-SCD
- Lead sponsor
- University Hospital, Clermont-Ferrand
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 1, 2026
- Completion date
- July 1, 2033
- Enrollment
- 400 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.
myocardial infarction (mi), sudden cardiac death due to cardiac arrhythmia